[1]
J. Landers, C. Walker, and T. Skaddy, “Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease”, J Neurol Res, vol. 16, no. 3, pp. 150–157, Jan. 2026, doi: 10.14740/jnr1122.